Trial Profile
A Randomized, Open-label Study to Compare the Effect of CellCept Plus Corticosteroids, and Cyclophosphamide Plus Corticosteroids Followed by Azathioprine, on Remission Rate in Patients With Lupus Nephritis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 07 Oct 2014
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary) ; Azathioprine; Corticosteroids; Cyclophosphamide
- Indications Lupus nephritis
- Focus Therapeutic Use
- Sponsors Roche
- 22 Sep 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 02 Oct 2009 New trial record.